Assessing the impact of COVID‐19 on registered interventional clinical trials
Abstract The coronavirus disease 2019 (COVID‐19) pandemic has led to a dramatic impact worldwide and presented unprecedented challenges for clinical and translational medicine. We assess the impact of COVID‐19 on submitted and completed interventional clinical trials that have been registered on Cli...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-05-01
|
| Series: | Clinical and Translational Science |
| Online Access: | https://doi.org/10.1111/cts.13034 |